These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25901734)

  • 1. Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention.
    Zhang JH; Wang J; Tang XF; Yao Y; Zhang Y; Ma YL; Xu B; Gao RL; Song L; Gao Z; Chen J; Wu Y; Yang YJ; Meng XM; Yuan JQ
    Platelets; 2016; 27(1):75-9. PubMed ID: 25901734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.
    Motovska Z; Kvasnicka J; Hajkova J; Kala P; Simek S; Bobcikova P; Petr R; Bilkova D; Poloczek M; Miklik R; Fischerova M; Maly M; Widimsky P
    Atherosclerosis; 2010 Oct; 212(2):548-52. PubMed ID: 20691446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction.
    Zhang JH; Tang XF; Zhang Y; Wang J; Yao Y; Ma YL; Xu B; Gao RL; Gao Z; Chen J; Song L; Wu Y; Meng XM; Yuan JQ
    Thromb Res; 2014 Nov; 134(5):970-5. PubMed ID: 25217066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction.
    Motovska Z; Kvasnicka J; Widimsky P; Petr R; Hajkova J; Bobcikova P; Osmancik P; Odvodyova D; Katina S
    Thromb Res; 2010 Feb; 125(2):e61-4. PubMed ID: 19786296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
    Sionova M; Blasko P; Jirous S; Vindis D; Rokyta R; Motovska Z
    Postepy Kardiol Interwencyjnej; 2017; 13(3):202-209. PubMed ID: 29056992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.
    Verschuren JJ; Boden H; Wessels JA; van der Hoeven BL; Trompet S; Heijmans BT; Putter H; Guchelaar HJ; Schalij MJ; Jukema JW
    Int J Cardiol; 2013 Sep; 167(6):2882-8. PubMed ID: 22940005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention.
    Friedman EA; Texeira L; Delaney J; Weeke PE; Lynch DR; Kasasbeh E; Song Y; Harrell FE; Denny JC; Hamm HE; Roden DM; Cleator JH
    J Thromb Thrombolysis; 2016 May; 41(4):656-62. PubMed ID: 26446588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized ADP-receptor inhibition strategy and outcomes following primary PCI for STEMI (PASTOR study).
    Mikkelsson J; Paana T; Lepantalo A; Karjalainen PP
    Int J Cardiol; 2016 Jan; 202():463-6. PubMed ID: 26436674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
    Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
    Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.
    Giusti B; Gori AM; Marcucci R; Sestini I; Saracini C; Paniccia R; Poli S; Giglioli C; Valente S; Prisco D; Gensini GF; Abbate R
    Atherosclerosis; 2008 Jan; 196(1):341-348. PubMed ID: 17157856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Platelet Reactivity 2 Hours After P2Y₁₂ Receptor Antagonist Loading in Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction - Impact of Pain-to-Loading Time.
    Xanthopoulou I; Davlouros P; Tsigkas G; Koutsogiannis N; Patsilinakos S; Deftereos S; Hahalis G; Alexopoulos D
    Circ J; 2016; 80(2):442-9. PubMed ID: 26597388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible Genetic Predictors of Cardiovascular Complications After Coronary Artery Bypass Surgery].
    Grinshtein YI; Kosinova AA; Grinshtein IY; Subbotina TN; Savchenko AA
    Kardiologiia; 2018 Jul; 58(7):77-84. PubMed ID: 30081812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
    Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
    Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.